Compared with White women, Black women are more likely to be diagnosed with hypertension at a younger age, have higher blood pressure readings, and die earlier from complications related to hypertension.
The USPSTF concludes that current evidence is inadequate for assessing the balance of benefits and harms of screening children and adolescents for hypertension.
Adult patients with pulmonary arterial hypertension (PAH) who were also obese had worse disease-specific health-related quality of life compared to patients of normal weight.
There is a trend toward a decreasing age for diagnosis of cardiovascular disease and associated risk factors among women.
Treatment with ACEI and/or ARBs was not found to increase the rates of COVID-19 infection or associated mortality.
Racial inequities in treatment intensification may be responsible for more than 20% of racial disparities in hypertension control.
Transgender persons who present for gender-affirming hormone therapy may be at an elevated cardiovascular risk.
Researchers conducted a prospective study to analyze the relationship between continued angiotensin-converting enzyme inhibitor (ACEi) or angiotensin II receptor blocker (ARB) use in the hospital and better clinical outcomes (ICU admission, morbidity, mortality).
Self-measured BP monitoring at home may be a cost-effective way to improve the diagnosis and management of patients with hypertension.
Offspring of women with chronic hypertension were twice as likely to be hospitalized for an endocrine-related issue by the age of 18.
